首页 | 本学科首页   官方微博 | 高级检索  
     


Reactive oxygen species in cardiovascular disease
Authors:Sugamura Koichi  Keaney John F
Affiliation:
  • Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
  • Abstract:Based on the “free radical theory” of disease, researchers have been trying to elucidate the role of oxidative stress from free radicals in cardiovascular disease. Considerable data indicate that reactive oxygen species and oxidative stress are important features of cardiovascular diseases including atherosclerosis, hypertension, and congestive heart failure. However, blanket strategies with antioxidants to ameliorate cardiovascular disease have not generally yielded favorable results. However, our understanding of reactive oxygen species has evolved to the point at which we now realize these species have important roles in physiology as well as pathophysiology. Thus, it is overly simplistic to assume a general antioxidant strategy will yield specific effects on cardiovascular disease. Indeed, there are several sources of reactive oxygen species that are known to be active in the cardiovascular system. This review addresses our understanding of reactive oxygen species sources in cardiovascular disease and both animal and human data defining how reactive oxygen species contribute to physiology and pathology.
    Keywords:5-LO, 5-lipoxygenase   5-MTHF, 5-methyltetrahydrofolate   12-LO, 12-lipoxygenase   12/15-LO, 12/15-lipoxygenase   ACS, acute coronary syndrome   ApoA-I, apolipoprotein A-I   ApoE, apolipoprotein E   BH4, 5,6,7,8-tetrahydrobiopterin   CAD, coronary artery disease   CHD, coronary heart disease   CVD, cardiovascular disease   eNOS, endothelial nitric oxide synthase   GCH, GTP-cyclohydrolase   GPX-1, glutathione peroxidase-1   HDL, high-density lipoprotein   HF, heart failure   iNOS, inducible nitric oxide synthase   LDL, low-density lipoprotein   LDL-R, low-density lipoprotein receptor   LV, left ventricular   MI, myocardial infarction   Mn-SOD, manganese superoxide dismutase   MPO, myeloperoxidase   NADPH, nicotinamide adenine dinucleotide phosphate   nNOS, neuronal nitric oxide synthase   NOS, nitric oxide synthase   ox-LDL, oxidized low-density lipoprotein   PROBE, prospective randomized open blinded end-point   RCT, randomized controlled trial   ROS, reactive oxygen species
    本文献已被 ScienceDirect PubMed 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号